| # | Drug | Count |
|---|---|---|
| 0 | METHADONE | 18 |
| 1 | TACROLIMUS | 14 |
| 2 | TRASTUZUMAB | 14 |
| 3 | FENTANYL | 13 |
| 4 | QUETIAPINE | 13 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 |
| 6 | TACROLIMUS OINTMENT 0.1% | 13 |
| 7 | CAPECITABINE | 12 |
| 8 | DEXAMETHASONE | 11 |
| 9 | DEXAMETHASONE 1.5 MG | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0084 |
| 1 | BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE | 1 | 0.0022 |
| 2 | MEPIVACAINE HYDROCHLORIDE | 2 | 0.0017 |
| 3 | GLYCOPYRROLATE | 8 | 0.0014 |
| 4 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 2 | 0.0014 |
| 5 | BUPIVACAINE | 10 | 0.0011 |
| 6 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 8 | 0.0010 |
| 7 | DHEA (DEHYDROEPIANDROSTERONE) | 2 | 0.0010 |
| 8 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 9 | SALINE NASAL SPRAY | 4 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 32 |
| 1 | Opioid Agonist [EPC] | 21 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 4 | Atypical Antipsychotic [EPC] | 16 |
| 5 | Benzodiazepine [EPC] | 16 |
| 6 | Amide Local Anesthetic [EPC] | 14 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 14 |
| 8 | Aromatase Inhibitor [EPC] | 13 |
| 9 | Kinase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 5 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 6 | General Anesthetic [EPC] | 11 | 0.0003 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 8 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 14 | 0.0002 |